Evidence map›Paper›PMID 28579769›Full record

ArticleInternational journal of chronic obstructive pulmonary disease2017

Ampicillin resistance in

Satyanarayana Maddi, Umme Kolsum, Sarah Jackson, Richard Barraclough, Barbara Maschera, Karen D Simpson, Thierry G Pascal, Serge Durviaux, Edith M Hessel, Dave Singh

Open access · goldAbstract read
In one paragraph

Article in International journal of chronic obstructive pulmonary disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Exploiting haem-iron dependence of nontypeableFrontiers in cellular and infection microbiology · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Epidemiology of Haemophilus influenzae in the Republic of Ireland, 2010-2018.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Antimicrobial susceptibility amongInfection and drug resistance · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Satyanarayana MaddiDivision of Infection, Immunity and Respiratory Medicine, Medicines Evaluation Unit, University Hospital of South Manchester Foundation Trust, University of Manchester.
Umme KolsumDivision of Infection, Immunity and Respiratory Medicine, Medicines Evaluation Unit, University Hospital of South Manchester Foundation Trust, University of Manchester.
Sarah JacksonDivision of Infection, Immunity and Respiratory Medicine, Medicines Evaluation Unit, University Hospital of South Manchester Foundation Trust, University of Manchester.
Richard BarracloughDepartment of Respiratory Medicine, University Hospital of South Manchester Foundation Trust, Manchester.
Barbara MascheraRefractory Respiratory Inflammation DPU, GlaxoSmithKline Medicines Research Centre, Stevenage, Hertfordshire, UK.
Karen D SimpsonRefractory Respiratory Inflammation DPU, GlaxoSmithKline Medicines Research Centre, Stevenage, Hertfordshire, UK.
Thierry G PascalClinical Laboratory Sciences, GlaxoSmithKline Vaccines, Wavre, Belgium.
Serge DurviauxClinical Laboratory Sciences, GlaxoSmithKline Vaccines, Wavre, Belgium.
Edith M HesselRefractory Respiratory Inflammation DPU, GlaxoSmithKline Medicines Research Centre, Stevenage, Hertfordshire, UK.
Dave SinghDivision of Infection, Immunity and Respiratory Medicine, Medicines Evaluation Unit, University Hospital of South Manchester Foundation Trust, University of Manchester.
Medicines Evaluation Unit · GBGlaxoSmithKline (United Kingdom) · GBGlaxoSmithKline (Belgium) · BEManchester University NHS Foundation Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPATIENTS AND

methodsSputum sampling was performed in 61 COPD patients, with 42 samples obtained at baseline;

resultsDisk diffusion showed the highest antibiotic resistance in the penicillin antibiotic group (eg, 67% for ampicillin) and macrolides (eg, 46% for erythromycin), whereas all isolates were susceptible to quinolones. Of the 16 isolates resistant to ampicillin, 9 (56%) were β-lactamase positive. The β-lactamase-negative isolates were further investigated; none of these fulfilled the phenotypic BLNAR classification criteria of ampicillin minimum inhibitory concentration >1 µg/mL, and only one demonstrated an

conclusionWe observed an overidentification of ampicillin resistance by disk diffusion. The majority of ampicillin resistance was due to enzyme production.

Indexed as

Ampicillin ResistanceDrug Resistance, Multiple, BacterialAgedAmpicillinAnti-Bacterial AgentsCross-Sectional StudiesDisk Diffusion Antimicrobial TestsFemaleGenotypeHaemophilus InfectionsHaemophilus influenzaeHumansLungMaleMiddle AgedPneumonia, BacterialAmpicillinAnti-Bacterial Agentsampicillin resistanceBLNARCOPDMLST

Identifiers

PMID28579769
PMCPMC5446963
OpenAlexW2620088010

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.